文献速递主动脉疾病

TEVAR术后入路相关并发症的性别差异:GORE GREAT注册研究分析

Gender Related Access Complications After TEVAR: Analysis from the Retrospective Multicentre Cohort GORE® GREAT Registry Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-05-10

基于GORE GREAT回顾性多中心注册研究,分析887例仅使用GORE TAG胸主动脉覆膜支架行TEVAR的患者,总体入路相关并发症发生率为2.8%,女性为4.7%、男性为1.8%(p=.013)。校正年龄、紧迫性、器械直径、鞘管尺寸、入路血管直径及入路方式后,女性性别(OR 2.85;p=.038)和肱动脉入路(OR 8.32;p<.001)均为入路相关并发症的独立预测因素。

要点

  • 女性TEVAR术后入路相关并发症发生率高于男性(4.7% vs 1.8%,p=.013)。
  • 校正混杂因素后女性性别仍与入路并发症独立相关(OR 2.85;p=.038)。
  • 肱动脉入路是入路相关并发症的独立预测因素(OR 8.32;p<.001)。

核心结论

  • 女性TEVAR术后入路相关并发症发生率可能高于男性,且不受临床情境、主动脉疾病类型和器械尺寸选择影响。
  • 肱动脉入路与入路相关并发症风险显著升高独立相关。

研究设计与样本

  • 多中心、观察性、回顾性队列研究,基于GORE GREAT赞助注册数据库。
  • 共纳入887例因各种胸主动脉疾病仅使用Conformable GORE TAG或GORE TAG胸主动脉覆膜支架行TEVAR的患者。

主要发现

  • 总体入路相关并发症发生率为2.8%(n=25)。
  • 女性入路相关并发症发生率为4.7%(n=14),男性为1.8%(n=11),p=.013。
  • 手术指征以退行性动脉粥样硬化性动脉瘤(n=414,46.7%)和B型夹层(n=270,30.4%,复杂或非复杂)为主。
  • 校正年龄、紧迫性、器械直径、导引鞘(≥24Fr vs ≤24Fr)、入路血管直径和入路方式后,女性性别与入路并发症风险显著相关(OR 2.85;p=.038)。
  • 肱动脉入路为入路相关并发症的独立预测因素(OR 8.32;p<.001)。

关键数值与推荐

  • 入路相关并发症定义包括:手术部位感染、假性动脉瘤、撕脱、夹层、动脉出血、入路血管血栓形成/闭塞、血清肿和淋巴囊肿。
  • 导引鞘尺寸分组:≥24Fr vs ≤24Fr。
  • 校正因素包括年龄、紧迫性、器械直径、导引鞘尺寸、入路血管直径和入路方式。

临床怎么用

  • 对女性患者TEVAR术前应更仔细评估入路血管条件并制定入路并发症预防策略。
  • 选择肱动脉入路时应权衡入路相关并发症风险,可能需优先考虑其他入路方式。

局限性

  • 回顾性赞助注册研究设计,可能存在选择偏倚和数据报告不完整。
  • 仅纳入使用GORE TAG胸主动脉覆膜支架的患者,结果外推需谨慎。
  • 入路相关并发症事件数较少(n=25),统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Global Registry for Endovascular Aortic Treatment (GREAT), a retrospective sponsored registry, was queried to determine the incidence and identify potential predictors of access related complications after TEVAR. METHODS: This is a multicentre, observational cohort study. For the current study, all patients were treated only with the Conformable GORE® TAG® Thoracic Endoprosthesis and GORE® TAG® Thoracic Endoprosthesis devices for any kind of thoracic aortic disease. All serious adverse events within 30 days of the procedure were documented by sites. The following were considered access related complications: surgical site infection, pseudoaneurysm, avulsion, dissection, arterial bleeding, access vessel thrombosis/occlusion, seroma, and lymphocoele. RESULTS: A total of 887 patients was analysed: most of the cases had an operative indication for TEVAR of degenerative atherosclerotic aneurysm (n = 414, 46.7%) and type B dissection (n = 270, 30.4% either complicated or uncomplicated). Two hundred and ninety-five patients (33.3%) were female. The overall access related complication rate was 2.8% (n = 25): 4.7% (n = 14) in women and 1.8% (n = 11) in men (p = .013). After adjustment for age, urgency, device diameter, introducer sheath (≥24Fr vs. ≤ 24Fr), access vessel diameters, and access method, female gender was significantly associated with the risk of access complications (OR 2.85; p = .038). Brachial artery for access was also found to be an independent predictor of access related complications (OR 8.32; p < .001). CONCLUSION: This analysis suggests that women may have a higher access related complication rate after TEVAR, irrespective of the clinical setting, type of aortic disease, and device sizing.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Lomazzi C, Mascoli C, de Beaufort HWL, et al. Gender Related Access Complications After TEVAR: Analysis from the Retrospective Multicentre Cohort GORE® GREAT Registry Study. Eur J Vasc Endovasc Surg. 2020. PMID: 32402803. doi:10.1016/j.ejvs.2020.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。